baber/WOPTO huggingface dataset:
Patent MX-2017012815-A (MX)
Title: Natural-substance combination containing at least one glycyrrhetinic acid and at least one guggelsterone and use thereof for cosmetic applications.
Inventor: LUTZ WEBER
IPC: A61K9/127
Filed: 2016-04-12
Abstract: The invention relates to a natural-substance combination containing at least one glycyrrhetinic acid and at least one guggulsterone, and to the use thereof for cosmetic applications. The invention relates in particular to vesicles (in particular for topical application) that contain at least one glycyrrhetinic acid and at least one guggulsterone. Said vesicles are preferably added to a cream, a lotion, or a gel, wherein the resulting cream, the resulting lotion, or the resulting gel is used for the cosmetic and/or dermatological treatment of the skin and/or for preventing the manifestation of cellulite and/or aged skin and/or for treating changes in the subcutaneous fat tissue or connective tissue, such as lipomas and other unspecific subcutaneous fat deposits, or for resolving or reducing non-pathological fat pads, such as fat pads in the face and neck region, for example lachrymal sacs.
Patent MX-2017014816-A (MX)
Title: High manganese 3rd generation advanced high strength steels.
Inventor: THOMAS GRANT AARON
IPC: C22C38/04
Filed: 2016-05-20
Abstract: A high strength steel comprises up to about 0.25wt% C, up to about 2.0wt%Si, up to about 2.0wt% Cr, up to 14% Mn, and less than 0.5% Ni. It preferably has an Ms temperature less than 50°C. The high strength steel may have a tensile strength of at least 1000 MPa and total elongations of at least about 25% after hot rolling. It may have a tensile strength of at least 1200 MPa and total elongations of at least about 20% after hot rolling.
Patent MX-2017015859-A (MX)
Title: Wall anchor assemblies.
Inventor: GARY E WILL
IPC: F16B2/10
Filed: 2016-06-28
Abstract: An anchor assembly for hanging an object on a wall includes a first anchor component and a second anchor component. The first anchor component includes a base having front, back, top, bottom, left and right sides, and at least one wall penetrating retainer extending from the base and having a wall penetrating extent that protrudes rearwardly of the base and has a downwardly curved configuration. The second anchor component includes a base having front, back, top, bottom, left and right sides, at least one wall penetrating retainer extending from the base of the second anchor component and having a wall penetrating extent that protrudes rearwardly of the base of the second anchor component and has a curved configuration. The second anchor component is pivotably associated with the first anchor component for movement between an anchoring orientation and a non-anchoring orientation.
Patent MX-2018000362-A (MX)
Title: New exendin-4 derivatives as selective peptidic dual glp-1 / glucagon receptor agonists.
Inventor: DIETER KADEREIT
IPC: C07K14/435
Filed: 2016-07-08
Abstract: The present invention relates to dual GLP-1 / glucagon receptor agonists and their medical use, for example in the treatment of disorders of the metabolic syndrome, including diabetes and obesity, as well as for reduction of excess food intake.
Patent MX-2018001419-A (MX)
Title: Managing a device cloud.
Inventor: Eran TAL
IPC: H04L29/06
Filed: 2016-08-05
Abstract: Particular embodiments of a gateway computing device may provide a provisioning service for access credentials for a restricted network. The gateway computing device may receive, from a client device, a request for the access credentials, wherein the request was sent over an open network using a restricted-packet-size protocol designed to limit power usage by devices sending messages using the protocol. The gateway computing device may segment data comprising the access credentials into a plurality of packets, wherein the plurality of packets conform to the restricted-packet-size protocol. Finally, the gateway computing device may send, over the open network to the client device, the segmented data using the restricted-packet-size protocol.
Patent MX-2018002068-A (MX)
Title: Purification of fkpa and uses thereof for producing recombinant polypeptides.
Inventor: CHRIS B FONG
IPC: C07K16/12
Filed: 2016-08-19
Abstract: The present invention provides methods for producing FKBP-type peptidyl-prolyl cis-trans isomerase (FkpA) polypeptides at very high levels of purity. Also provided are ultrapure FkpA and methods of using same, e.g., for use in immunoassays to show removal of FkpA from biologies produced in bacteria. In addition, the present invention provides methods of purifying polypeptides (e.g., multispecific antibodies) produced in bacteria overexpressing one or more chaperones. The methods include affinity chromatography, mixed-mode chromatography and hydrophobic interaction chromatography. In some aspects, the invention provides compositions of polypeptides (e.g., multispecific antibodies) that are essentially free of product-specific impurities.
Patent MX-2018002419-A (MX)
Title: Norovirus vaccine.
Inventor: Ron cobb
IPC: A61K39/12
Filed: 2016-08-26
Abstract: A dry powder norovirus vaccine is provided, which comprises at least two norovirus antigens representing different genogroups. The vaccine may be produced by formulation with a mixture of different antigens or combination of monovalent powders with each containing one antigen. The formulated vaccine is suitable for mucosal administration and soluble in aqueous solutions for parenteral administration. A method of immunization is also provided, which comprises at least one administration of the vaccine via mucosal and/or parental route. The immunization may have multiple administrations of the vaccine, i.e., one or more immunizations via a mucosal route followed by one or more immunizations via a parenteral route or vice versa, to maximize both mucosal and systemic immune responses and protection against norovirus infections.
Patent MX-2018003476-A (MX)
Title: Cold sintering ceramics and composites.
Inventor: CLIVE A RANDALL
IPC: C04B35/622
Filed: 2016-09-26
Abstract: Cold sintering of materials includes using a process of combining at least one inorganic compound, e.g., ceramic, in particle form with a solvent that can partially solubilize the inorganic compound to form a mixture; and applying pressure and a low temperature to the mixture to evaporate the solvent and densify the at least one inorganic compound to form sintered materials.
Patent MX-2018003497-A (MX)
Title: Modified release orally administered amino acid formulations.
Inventor: GIORGIO REINER
IPC: A61K9/50
Filed: 2016-09-27
Abstract: Methods and formulations of modified release amino acids are provided for the treatment or management of diseases defined by impaired amino acid metabolism, with improved pharmacokinetics, metabolism and utilization.
Patent MX-2018003687-A (MX)
Title: Signaling high dynamic range and wide color gamut content in transport streams.
Inventor: AJAY LUTHRA
IPC: H04N19/70
Filed: 2016-09-23
Abstract: A program map table in a transport stream comprising an elementary stream identifier indicating a particular elementary stream, a high dynamic range flag indicating the presence or absence of high dynamic range content within the elementary stream, and a wide color gamut flag indicating the presence or absence of wide color gamut content within the elementary stream.
Patent MX-2018003706-A (MX)
Title: Methods for improving the gastrointestinal tolerance of food and beverage products comprising sweet, low-digestible carbohydrates.
Inventor: RYAN D WOODYER
IPC: A23L27/30
Filed: 2016-09-21
Abstract: The present invention relates to methods for improving the gastrointestinal tolerance of food and beverage products comprising sweet, low-digestible carbohydrates, and the use of one or more of D-glucose, fiber and protein for improving the gastrointestinal tolerance of food and beverage products comprising sweet, low-digestible carbohydrates.
Patent MX-2018004039-A (MX)
Title: Human antibodies to human tnf-like ligand 1a (tl1a).
Inventor: CLASSON BRENDAN J
IPC: A61K39/395
Filed: 2013-05-07
Abstract: A fully human antibody or antigen-binding fragment of a human antibody that specifically binds and inhibits human TNF-like ligand 1A (hTL1A) is provided. The human anti-hTL1 A antibodies are useful in treating diseases or disorders associated with TL1 A, such as inflammatory diseases or disorders, such as inflammatory bowel diseases, including ulcerative colitis and Crohn's disease, rheumatoid arthritis, and the like; autoimmune diseases or disorders, such as multiple sclerosis, diabetes, and the like; and allergic reactions, such as asthma and allergic lung inflammation.
Patent MX-2018005784-A (MX)
Title: Hemostatic mixture of cellulose-based short and long fibers.
Inventor: DHANARAJ SRIDEVI
IPC: A61L24/00
Filed: 2016-11-08
Abstract: The invention relates to a hemostatic composition comprising a mixture of cellulose- based short and long fibers, preparation and use thereof.
Patent MX-2018006284-A (MX)
Title: Electrical connector with recordable position assurance.
Inventor: THOMAS ROBERT DEWITTE
IPC: H01R13/641
Filed: 2016-11-21
Abstract: An electrical connector (102) with recordable position assurance includes a housing (118), an indicating feature (162), and a concealing feature (134). The housing is configured to engage a mating connector (104) during a mating operation. The indicating feature has a visual identifier disposed thereon. The indicating feature and the concealing feature are movable relative to each other between a concealed position and an exposed position. The concealing feature conceals at least a portion of the visual identifier in the concealed position. The visual identifier is exposed or exposable in the exposed position. The indicating feature is in the exposed position relative to the concealing feature when the housing is fully mated to the mating connector, and is in the concealed position relative to the concealing feature when the housing and mating connector are not fully mated.
Patent MX-2018008549-A (MX)
Title: Pharmaceutical composition comprising quinoline derivative or salt thereof.
Inventor: YUN LU
IPC: A61K9/20
Filed: 2017-01-23
Abstract: The present invention provides a pharmaceutical composition comprising a quinoline derivative or a salt thereof. Specifically, the invention provides a pharmaceutical composition comprising an (R,E)-N-(4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)-3-cyan o-7-ethoxyquinolin-6-yl)-3-(1-methylpyrrolidin-2-yl)-propeneamide or a pharmaceutically acceptable salt thereof, a cross-linked polyvinylpyrrolidone, and at least one pharmaceutically acceptable excipient. The pharmaceutical composition has a property of rapid dissolution.
Patent MX-2018012076-A (MX)
Title: Anti-tim-3 antibodies and compositions.
Inventor: MIKKEL WANDAHL PEDERSEN
IPC: A61P35/00
Filed: 2017-04-11
Abstract: This invention relates to anti-TIM-3 antibodies and antibody compositions and their use in enhancing immunity in a patient, e.g., to treat cancer.
Patent MX-2018013811-A (MX)
Title: Variable flow resistance for use with an underground well.
Inventor: LIANG ZHAO
IPC: E21B43/12
Filed: 2014-05-07
Abstract: The present invention relates to a variable flow resistance system for use with an underground well including a structure that shifts with a flow of a fluid composition, thereby changing resistance to flow with a change in the desired or undesired fluid ratio. Also, it includes a structure that rotates with a fluid flow composition and a fluid switch detecting said composition related to two flow paths. Further, it involves a structure that moves with the fluid flow composition and resistance to flow with a change in the desired or undesired fluid ratio. Finally, the present invention uses inflatable materials and supporting surfaces.
Patent MX-2018014178-A (MX)
Title: Anti-fgfr2 antibody.
Inventor: HASEGAWA JUN
IPC: C07K16/40
Filed: 2014-10-09
Abstract: An antibody which bonds with fibroblast growth factor receptor.
Patent MX-2018014192-A (MX)
Title: Solenoid valve.
Inventor: SHINICHI YOSHIMURA
IPC: F16K31/06
Filed: 2017-05-10
Abstract: [Problem] To alleviate external forces such as compressive force which act on a valve when a valve seats on a valve seat, thereby minimizing wear and/or irreversible deformation sustained by the valve as a result of the repeated action of such an external force on the valve, and minimizing fluctuations in responsiveness of the solenoid valve and/or the flowrate of fluid that flows through the valve seat. [Solution] A valve operation member 40 is equipped with a valve support (supporting arm 45) that supports the valve 3 with respect to the valve operation member 40 while allowing relative movement in the axial direction L. Inside the valve chamber 11, the valve 3 is constantly impelled towards the valve seat side in the axial direction L, an elastic member 26 which seats the valve in the valve seat as a result of the impelling force thereof is provided, the valve support is provided with a valve engaging part 73 that moves the valve away from the valve seat by engaging a part to be engaged 4 of the valve 3 seated in the valve seat, and the valve engaging part 73 is not in contact with the valve 3 in the axial direction L in the state in which the valve 3 is seated in the valve seat.
Patent MX-2018014829-A (MX)
Title: Veterinary compositions and uses thereof to control parasites in non-human mammals.
Inventor: BERGSON FOGACA DE OLIVEIRA
IPC: A61K36/00
Filed: 2018-11-30
Abstract: Veterinary compositions and uses thereof to control parasites in non-human mammals. The present invention relates to a veterinary composition comprising flumethrin, fluazuron and propylene glycol monomethyl ether in a veterinary acceptable carrier. The invention also relates to the use of such compositions for controlling ectoparasites in a non-human mammal.
Patent MX-2018015025-A (MX)
Title: Microprocessor-controlled system for human physical training.
Inventor: CARLOS ALBERTO LEOPOLDO DA CMARA FILHO
IPC: G01L1/00
Filed: 2017-01-24
Abstract: The present invention is used in the field of gymnastics equipment, muscle-building and muscle-strengthening apparatus. The invention describes a system used in gymnastics equipment, preferably for performing muscle-building exercises without using counterweights, wherein the system is based on the speed of movement, independently of the force applied.
Patent MX-2018015203-A (MX)
Title: Sclerosing solution.
Inventor: ANA MARIA MAR GUTIERREZ
IPC: A61K31/60
Filed: 2018-12-06
Abstract: The present invention relates to a sclerosant solution useful in the treatment of sclerotherapy. Said formulation comprises sodium salicylate mixed with distilled water, as well as another active ingredient of Glucose mixed with distilled water, with a process to prepare said composition. Further, the present invention relates to the use of the said solution as a medicine for the treatment of chronic venous diseases.
Patent MX-2019000765-A (MX)
Title: Estimation of improved coverage of wireless cellular networks by inactive mode measurements of user equipment (eu).
Inventor: CHOU JOEY
IPC: H04W36/00
Filed: 2016-06-02
Abstract: The present invention aims to provide devices, systems, and methods for estimating improved coverage of wireless cellular networks through measurement and reporting of User Equipment (UE) idle mode. It includes a signal measurement module to measure a reference signal received power (RSRP) from a serving cell of the UE in an idle mode for determining if the RSRP is below a value threshold. Also, it comprises a cell search and selection module for searching a neighboring cell in response and go to the neighboring cell if the search is successful. Further, it includes a data-recording module to record information associated with the neighboring cell and to record information associated with the serving cell if the neighbor cell search fails.
Patent MX-2019003093-A (MX)
Title: Crystalline forms.
Inventor: MARKUS VON RAUMER
IPC: A61K31/675
Filed: 2017-09-21
Abstract: The invention relates to crystalline forms of 4-((R)-2-{[6-((S)-3-methoxy-pyrrolidin-1-yl)-2-ph enyl-pyrimidine-4-carbonyl]-amino}-3-phosphono-propionyl)-pipera zine-1-carboxylic acid butyl ester hydrochloride, processes for the preparation thereof, pharmaceutical compositions comprising said crystalline forms, pharmaceutical compositions prepared from such crystalline forms and their use as a medicament, especially as a P2Y12 receptor antagonist.
Patent MX-2019004668-A (MX)
Title: A system and method for calibrating a centrifuge.
Inventor: MILLIE CLIVE-SMITH
IPC: G01N33/49
Filed: 2017-10-10
Abstract: A sample holder for use in a centrifuge, the sample holder being generally planar and comprising: an aperture or recess for releasably retaining a sample storage member including a sample chamber adapted to contain a volume of liquid; a centre point around which the holder will rotate during use; and one or more calibration features, wherein the calibration feature(s) comprise one or more outer edges, which lie on the side of the or each calibration feature which is furthest from the centre point, and the one or more outer edges comprise a series of radially spaced-apart outer edge portions or positions which are spaced at different distances from the centre point as a function of angular position around the centre point.
Patent MX-2019005610-A (MX)
Title: System and method for data exchange and control with a wireless communication terminal on a welding system.
Inventor: MARC LEE DENIS
IPC: B23K9/00
Filed: 2016-04-04
Abstract: A system and method for determining providing a welding-type system capable of wirelessly controlling, monitoring, and updating various welding parameters from a remote device using a single remote control. The welding-type device includes a welding power source with a radio apparatus capable of operating as a wireless communication terminal (WCT) to communicate with a terminal device and provide a user interface for data and file exchange.
Patent MX-2019008894-A (MX)
Title: Purification of pleuromutilin.
Inventor: WERNER HEILMAYER
IPC: C07C69/675
Filed: 2018-02-09
Abstract: The present invention relates to purification methods of pleuromutilin (I) by means of crystallisation and/or recrystallisation. The process according to the present invention is carried out in the presence of i-propylacetate.
Patent MX-2019010430-A (MX)
Title: Equibiotic compositions that induce the balance of the intestinal microbiota, useful for the treatment of dysfunctional diseases of the digestive tract.
Inventor: LOZOYA LEGORRETA Javier
IPC: A61P1/14
Filed: 2019-09-02
Abstract: The present invention discloses compositions comprising standardized extracts obtained from the leaves of Psidium Guajava (Myrtaceae) and the roots of Coptis Chinensis Franch (Ranunculaceae). Said compositions contribute to the restoration of the intestinal microbiota when the digestive tract is found, injured, or infected. Also, it has useful effects for treating dyspepsia and gastrointestinal dysbiosis.
Patent MX-2019013189-A (MX)
Title: In-situ barrier device with internal injection conduit.
Inventor: ROBERT A WIERCINSKI
IPC: E21D11/38
Filed: 2018-05-10
Abstract: The present invention provides a multi-layer barrier assembly or device for post- installation injection of a resin, grout, or other fluid fluid. The barrier device comprises first and second layers defining an intermediate open-matrix layer, and at least one injection conduit member in parallel orientation with respect to the first and second layers and having openings for injecting fluid into the intermediate open-matrix layer. The injection conduit may be located between and in parallel orientation with respect to the first and second layers, along an edge of the first and/or second layers, along an outer face of the first layer (if the first layer is a woven or nonwoven fabric), or at any combination of these locations, to enable fluid to be conveyed into the intermediate open-matrix layer. The invention also provides for use of a gel activator within the barrier device cavity, such as pre-installed on open-matrix structure which used for separating the first and second layers of the barrier device, such that a highly flowable injection fluid can be introduced into the device, and its gelation or hardening will be initiated or accelerated by the presence of the gel activator. This will allow for low power grout pumps to be used and facilitate the sealing of fine cracks in the surrounding concrete.
Patent MX-2019013512-A (MX)
Title: Force amplification device of a mechanism for generating energy.
Inventor: DURAN HINOJOSA SERGIO
IPC: F03B13/00
Filed: 2019-11-12
Abstract: The present invention relates to a force amplification device of mechanism for generating energy. Currently, a series of liquid containers drive a drum or water wheel with a configuration where the liquid remains for a short time in a working condition since the drum modifies the inclination thereof. Herein, the water is poured out of them for a quick or substantial empty; the longitudinal edge is located below the level of the water mirror, exerting little force by the weight retained therein, generating rotation in the axis of a drum. The present invention aims to solve the problem of the demand for energy by re-pumping and transmission mechanisms. Also, it aims to drive means for harnessing energy by the weight of the water housed therein and a series of levers coupled to a shaft of a transmission device for generating power. Herein, the mechanical elements compensate the power demand, improving its use and retaining the captured liquid for dislodging when closed from its longitudi nal edges.
Patent MX-2019014018-A (MX)
Title: Inhaler with synthetic jetting.
Inventor: ROBERT LEONARD
IPC: A61M15/00
Filed: 2018-05-22
Abstract: A dry powder inhaler consisting of a reusable base unit and a disposable drug package is disclosed. The reusable portion may house a transducer, a controller, battery and user interface. The disposable portion may house a dose pellet in a sealed dose chamber that includes an integrated mouthpiece. A user may couple the disposable portion to the reusable portion of the inhaler. The inhaler may sense the user's breathe and synchronize delivery of the pharmaceutical or drug to the user.
Patent MX-2019014858-A (MX)
Title: A method of manufacturing an opening system for a container.
Inventor: PIETRO MARTINI
IPC: B29C45/14
Filed: 2018-06-29
Abstract: A method of manufacturing an opening system for a container is disclosed. The container comprises a packaging material having an outside and an inside, and a strip zone arranged in the packaging material and being configured to be opened when opening the container. The method comprises molding an injection molded opening element by pressurizing a material from which the opening element is to be formed so that said material propagates from the inside of the packaging material to the outside thereof, through the strip zone, while having arranged a support element at the outside of the packaging material to contact at least part of the strip zone and at least part of the packaging material at a first portion thereof outside the strip zone, along a plane in which the packaging material extends, where said material propagates. An opening system for a container and a mold for manufacturing an opening system is also disclosed.
Patent MX-2019014885-A (MX)
Title: Amorphous and crystalline forms of ido inhibitors.
Inventor: HILARY PLAKE BECK
IPC: A61K31/437
Filed: 2018-06-29
Abstract: The present disclosure relates to amorphous and crystalline forms of (R)-N-(4- chlorophenyl)-2-((lS,4S)-4-(6-fluoroquinolin-4-yl) cyclohexyl)propanamide and its salts and hydrates, processes for their production, pharmaceutical compositions comprising them, and methods of treatment using them.